Conmed Corp (EC8.BE)
| Previous Close | 63.50 |
| Open | 65.50 |
| Bid | 65.50 x 0 |
| Ask | 66.00 x 0 |
| Day's Range | 65.50 - 65.50 |
| 52 Week Range | 57.50 - 125.00 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
CONMED Corporation to Present at the BofA Securities Healthcare Conference
LARGO, Fla., May 01, 2024--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat Beyer, Chief Operating Officer, will present at the BofA Securities Healthcare Conference at 2:20 p.m. PT (5:20 p.m. ET) on Tuesday, May 14, 2024 in Las Vegas, NV.
- Business Wire
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
LARGO, Fla., April 24, 2024--CONMED Corporation (NYSE: CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer (COO), effective immediately. In this role, Mr. Beyer will take on additional responsibility for leading the Company’s commercial businesses, as well as Operations, Distribution, Regulatory Affairs / Quality Assurance, and Customer Excellence.
- Business Wire
CONMED Corporation Announces First Quarter 2024 Financial Results
LARGO, Fla., April 24, 2024--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2024.
